News/ News/ Sales and Marketing Deals build Fresenius Kabi’s position in biosimilars, medtech Phil Taylor Biopharmaceutical, biosimilars, Fresenius Kabi, Ivenix, M&A, mAbxience, medical technology 0 Comment German injectable medicines specialist Fresenius Kabi has made a pair of deals to kickstart its new strategic direction, Share X Deals build Fresenius Kabi’s position in biosimilars, medtech https://pharmaphorum.com/news/deals-build-fresenius-kabis-position-in-biosimilars-medtech/